Trade Summary

2 days ago, MAHON PAUL A, serving as EVP & GENERAL COUNSEL at UNITED THERAPEUTICS Corp (UTHR), sold 8,300 shares at $523.14 per share, for a total transaction value of $4,342,079.03. Following this transaction, MAHON PAUL A now holds 45,172 shares of UTHR.

This sale represents a 15.52% decrease in MAHON PAUL A's stake in the company. This is considered a high-conviction trade given the significant change in ownership.

The trade was executed on Thursday, August 20, 2026 and publicly disclosed via SEC Form 4 filing on Friday, August 21, 2026 at 4:43 PM ET, 1 day after the trade was made.

UNITED THERAPEUTICS Corp operates in the HEALTHCARE sector, specifically within the DRUG MANUFACTURERS - SPECIALTY & GENERIC industry. Insider selling activity in this sector can provide valuable signals about industry trends and company-specific developments.